Beginning the month at 5.64%, 10-year Treasuries ended February at 6.13% - on the way to a May peak of 7.48% and November ...

Uncertainty surrounding President Trump’s import tariffs have been “cataclysmic” for the U.S. biotech industry, but the dust ...

Enjoy the ‘small town feel’ in one of the fastest-growing cities in the country during this weekend’s Georgetown Poppy ...

IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced the presentation of new ...

Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional ...

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to treat solid tumor cancers and chemotherapy-induced peripheral neuropathy (CIPN) ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Presentations at this year’s American Association for Cancer Research meeting could have a broad impact on the treatment ...

Real-world data indicated ART with DTG+3TC was effective and well tolerated among patients with HIV infection regardless of prior ART exposure.

What if business leaders approached strategy the way scientists design gene delivery vectors? In biotechnology, precision, ...

Holdings will be presenting a poster at the American Society of Clinical Oncology 2025 Annual Meeting to be held May ...